期刊文献+

氟尿嘧啶联合放疗对原发性肝癌患者治疗效果及对血清LPO、MDA水平的影响 被引量:11

The therapeutic effect of fluorouracil combined with radiotherapy on patients with primary liver cancer and its effect on serum LPO and MDA levels
原文传递
导出
摘要 目的探究氟尿嘧啶联合放疗对原发性肝癌患者的治疗效果及对血清过氧化脂(LPO)、丙二醛(MDA)水平的影响。方法选取2016年3月至2017年3月于恩施土家族苗族自治州中心医院肿瘤放疗中心接受治疗原发性肝癌患者108例,随机分为放疗组、联合治疗组各54例,放疗组患者进行放疗,联合治疗组患者使用氟尿嘧啶联合放疗进行治疗。对两组患者肝功能、凝血功能进行检测;酶联免疫吸附实验法检测肝纤维化指标水平,免疫透射比浊法检测LPO、MDA水平,对比两组患者治疗总有效率。结果治疗后联合治疗组患者AST、ALT、APTT、PT、HA、LN、PC-Ⅲ、LPO、MDA水平均低于放疗组(P均=0.001),差异有统计学意义(P<0.05)。联合治疗组治疗总有效率高于放疗组(P=0.023),差异有统计学意义(P<0.05)。结论使用氟尿嘧啶联合放疗对原发性肝癌患者进行治疗,能够改善患者肝功能及凝血功能,减轻患者肝纤维化及氧化应激反应严重程度,治疗效果显著。 Objective To explore the therapeutic effect of fluorouracil combined with radiotherapy on patients with primary liver cancer and its effect on the levels of serum lipid peroxide(LPO)and malondialdehyde(MDA).Methods From March 2016 to March 2017,a total of 108 patients with primary liver cancer were randomly divided into two groups:radiotherapy group and combined treatment group,with 54 cases in each group.The patients in the radiotherapy group were treated with radiotherapy,while the patients in the combined treatment group were treated with fluorouracil combined with radiotherapy.Biochemical assays were used to detect the levels of aspartate aminotransferase(AST),glutamyl transpeptidase(GGT),alanine aminotransferase(ALT),fibrinogen(FIB),activated partial thromboplastin time(APTT),and prothrombin time(PT).The enzyme-linked immunosorbent assay was used to detect serum hyaluronidase(HA),laminin(LN),and type III procollagen(PCIII)levels.The flow cytometry was used to detect T lymphocyte subgroup levels.LPO and MDA were detected by immunoturbidimetry.The total effective rate was compared between the two groups.Results The levels of AST,GGT and ALT in the combined treatment group were significantly lower than those in the radiotherapy group(P<0.05).After treatment,the FIB level in the combined treatment group was higher than that in the radiotherapy group,and the APTT and Pt levels were lower than those in the radiotherapy group(P<0.05).The levels of HA,LN and PCIII in the combined treatment group were lower than those in the radiotherapy group(P<0.05).After treatment,the CD8+level in the combined treatment group was lower than that in the radiotherapy group,while the CD4+and CD3+levels were higher than those in the radiotherapy group(P<0.05).The level of LPO and MDA in the combined treatment group was lower than that in the radiotherapy group(P<0.05).The total effective rate of the combined treatment group was higher than that of the radiotherapy group(P<0.05).Conclusion The treatment of primary liver cancer patients with fluorouracil combined with radiotherapy could improve the liver function and coagulation function,improve the immune function,and reduce the severity of liver fibrosis and oxidative stress response of patients.The effect of the combination treatment was significant.
作者 刘红艳 LIU Hongyan(Cancer Radiotherapy Center,The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture,Enshi,Hubei 445000,China)
出处 《公共卫生与预防医学》 2020年第1期105-108,共4页 Journal of Public Health and Preventive Medicine
基金 湖北省科技计划项目(2016CFB394)。
关键词 氟尿嘧啶 放疗 原发性肝癌 氧化应激 Fluorouracil Radiotherapy Primary liver cancer Oxidative stress
  • 相关文献

参考文献13

二级参考文献149

  • 1刘金明,张克勤,李涛.肝癌多次TACE术后的肝硬化分级及预后因素分析[J].实用癌症杂志,2014,29(1):68-71. 被引量:24
  • 2刘尚梅,赵建军,杨晓洁,胡敬群.肝细胞肝癌对机体细胞免疫的影响[J].实用癌症杂志,2005,20(1):68-70. 被引量:12
  • 3吴孟超.应重视小肝癌的诊断与治疗[J].中华医学杂志,2007,87(30):2089-2091. 被引量:11
  • 4Koh C, Zhao X, Samala N, et al. AASLD clinical practice guide- lines: a critical review of scientific evidence and evolving reco- mmendations[J]. Hepatology, 2013, 58(6): 2142-2152.
  • 5William H, Ralph H, Timothy H, et al. Surgical pathology dissec- tion: an illustrated guide[ M]. New York:Springer, 2003:7-9.
  • 6Bass BP, Engel KB, Greytak SR, et al. A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin- embedded ( FFPE ) tissue : how well do you know your FFPE specimen? [ J]. Arch Pathol Lab Med, 2014, 138(11): 1520-1530.
  • 7Lu XY, Xi T, Lau WY, et al. Hepatoeellular carcinoma expres- sing cholangiocyte phenotype is a novel subtype with highly aggressive behavior [ J ]. Ann Surg Oncol, 2011, 18 ( 8 ) : 2210-2217.
  • 8Cai SW, Yang SZ, Gao J, et al. Prognostic significance of mast cell count following curative resection for pancreatic ductal adeno- carcinoma[ J ]. Surgery, 201 l, 149 (4) : 576-584.
  • 9应越英.肝细胞肝癌的病理学//汤钊猷,主编.原发性肝癌[M].上海:上海科学技术出版社,1981:115-146.
  • 10Nakanuma Y, Curado MP, Franceschi S, et al. Intrahepatic cholangiocarcinoma//Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumours of the Digestive System[M]. 4th ed. Lyon:IARC Press, 2010: 217-227.

共引文献766

同被引文献122

引证文献11

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部